Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Trial of Phenelzine in Non-metastatic Recurrent Prostate Cancer

NCT02217709 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT02217709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02217709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Trial of Phenelzine in Non-metastatic Recurrent Prostate Cancer
Lead sponsor
University of Southern California
Phase
Phase 2
Overall status
Completed
Start date
September 8, 2014
Completion date
June 29, 2020
Enrollment
26 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of the prostate, recurrent prostate cancer, stage i prostate cancer, stage iia prostate cancer, stage iib prostate cancer, stage iii prostate cancer